BioNTech company profile
Company profile
BioNTech has 7,807 employees and is headquartered in Mainz, Germany.
The United States accounted for 62.5% of revenue in the fiscal year ended December 2025, ahead of Germany at 26.5% and Ireland at 10.6%. BioNTech SE, together with its subsidiaries, develops and commercializes immunotherapies, with its operations based in Germany. Its vaccine BNT162 is an mRNA product against SARS-CoV-2. The oncology pipeline includes drugs in Phase III trials, among them Gotistobart for metastatic non-small cell lung cancer and Pumitamig for small cell lung cancer, along with candidates for influenza, tuberculosis, malaria and mpox.
In the fiscal year ended December 2025, revenue reached EUR 2.9 billion, up 4.3% from the prior year, while the net loss came to EUR 1.1 billion. The company had 7,807 employees and is headquartered in Mainz, Germany, where it was incorporated in 2008.
Company facts
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Headquarters
- An der Goldgrube 12, 55131, Mainz
- Employees
- 7,807
- Chief executive
- Ugur Sahin
- Founded
- 2008
- Fiscal year
- January - December
- Listing
- BNTX · NASDAQ
- Currency
- USD
- ISIN
- US09075V1026
- Website
- biontech.de
BioNTech and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| BioNTechBNTX | United States | $21.22B | 7,807 | -55.4% | — |
| Alnylam PharmaceuticalsALNY | United States | $22.11B | 2,500 | 19.5% | 8.34 |
| IncyteINCY | United States | $24.36B | 2,844 | 32.2% | 61.0 |
| Ascendis PharmaASND | United States | $18.06B | 1,189 | 30.9% | 18.1 |
| InsmedINSM | United States | $26.96B | 1,664 | -41.7% | — |
| ExelixisEXEL | United States | $16.37B | 1,077 | 40.2% | 20.1 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
